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Summary 
Two-dimensional electrophoresis is still a very valuable tool in proteomics, due to its 
reproducibility and its ability to analyse complete proteins. However, due to its 
sensitivity to dynamic range issues, its mots suitable use in the frame of biomarker 
discovery is not on very complex fluids such as plasma, but rather on more proximal, 
simpler fluids such as CSF, urine, or secretome samples. Here, we describe the 
complete workflow for the analysis of such dilute samples by two-dimensional 
electrophoresis, starting from sample concentration, then the two-dimensional 
electrophoresis step per se, ending with the protein detection by fluorescence. 
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ii. Key Words: 2D-PAGE, fluorescence dyes, image analysis, sample preparation, 
secretome, biological fluids 
 
1. Introduction 
 
Proteomics in biomarker discovery suffers, maybe more acutely than other areas of 
proteomics, from two very important caveats. The first one is the necessity of 
analyzing rather large series of samples in order to take into account the 
interindividual variablility, and this is a very important requisite for the robustness of 
the biomarkers. The second caveat lies in the definition of the correct sample. 
Plasma and serum seem at a first glance as natural choices, as many clinical assays 
are usually performed on these body fluids. However, the effect of their tremendous 
complexity on the efficiency of the biomarker discovery process has been very often 
underestimated, and applying standard proteomic techniques to such complex fluids 
is generally not an efficient process [1]. Thus, more recent work as focused either on 
proximal fluids [2] such as CSF [3-7], or urine [8-10] or even samples of secreted 
proteins obtained from a relevant tissue or cell type model [11-15]. In this case, the 
implicit rationale is that it will be much easier to find tissue leakage specific markers 
in the secreted proteins, where they will be much more enriched than in plasma. 
Then, the presence and specificity of these putative biomarkers can be assessed in 
the clinically relevant sample (generally a body fluid like serum or plasma) by specific 
techniques, either antibody-based [16] or mass spectrometry-based [17].  
 
However, from a proteomic point of view, all these samples differ from serum and 
plasma in the fact that they are much more protein-poor and interfering substances-
rich, and there will be a major issue to solve in sample preparation for proteomic 
studies. 
 
Then, once the sample has been correctly prepared, there is a second crucial 
choice, i.e. the proteomic platform that will be used for biomarker discovery. Put 
rather bluntly, there is no discovery proteomic platform today  that combines 
sensitivity and reproducibility. 2D gel-based proteomics is by far the most 
reproducible platform in discovery proteomics, as exemplified by the much higher 
demands for gel-based publications in terms of sample numbers as compared to the 
demands for publishing shotgun proteomics experiments [18]. However, 2D gel-
based proteomics lacks sensitivity [19] and ignores some classes of proteins such as 
membrane proteins [20]. Conversely, shotgun proteomics techniques are much more 
sensitive and do not present so important protein classes biases. However, they 
cannot handle easily the large sample series required for biomarker discoveries.  
 
As to the targeted proteomics techniques, such as SRM/MRM, they need first a 
target to search for, i.e. to have a pre-determined analyte to search for. Moreover, 
when applied to complex body fluids such as plasma or serum, they are prone to 
artifacts resulting from spurious degradation of the peptides themselves [21-23].  
 
In this context, 2D gel-based proteomics is still a choice to consider in a biomarker 
discovery setup, taking advantage of its high reproducibility and its ability to resolve 
intact proteins. However, because of its rather poor sensitivity, 2D gel-based 
proteomics must be applied on carefully selected samples (typically not serum or 
plasma), which must be then carefully handled and concentrated. It is therefore not 
surprising that one of the very few success stories in proteomic discovered 
biomarkers has been made by 2D gel electrophoresis on CSF [24], and has led to 
deep clinical investigation of the serendipitous biomarkers discovered in this way 
(the 14-3-3 proteins)  in several brain pathologies [6], [25-27]. 
In addition, 2D gel-based proteomics offer unique capabilities when performing 
reverse probing, i.e. analyzing a patient immunological response to a pathogen to 
define pathognomonic profiles, as exemplified for candidiosis [28-29].  
 
Thus, this chapter will deal with two different aspects. The first one will be sample 
preparation, with a focus on sample cleaning and on protein concentration, and the 
second will be the 2D gel technology itself, with a focus on detection methods.  
 
 
2. Materials 
 
All solutions are made in ultrapure water (>15 megaohms/cm).  
 
2.1. Protein precipitation/resolubilization  
 
NLS solution: this solution consists of 10% (w/v) N-Lauroyl Sarcosinate in water. 
Dissolution is best obtained by using hot water. The solution must be kept at room 
temperature, but must be changed every 2 weeks 
 
TCA solution: this solution consists of 100% (w/v) tricholoroacetic acid in water. This 
can be either purchased ready-made (as a 6.1M solution of tricholoroacetic acid) or 
made by adding 450ml of water to a 1kg bottle of tricholoroacetic acid (see Note 1) 
 
Tetrahydrofuran, kept in the refrigerator 
 
Protein solubilization solution: this solution contains 7M urea, 2M thiourea, 4% 
CHAPS (w/v) , 20mM spermine base and 5mM Tris(carboxyethyl)phosphine (see 
Note 2). This solution is best prepared by sonication in a sonicating bath. It can be 
kept for months frozen at -20°C and thawed before use 
 
Carrier ampholytes, 3-10 range, sold as a 40% (w/v) solution. Stable for months at 
+4°C 
 
2.2. Isoelectric focusing 
 
IPG strips. They are availbale from several suppliers and in various pH ranges. Kept 
frozen at -20°C. For resolution reasons, it is recommended to use long (>15cm) 
strips. 
 
IPG rehydration solution: this solution contains 7M urea, 2M thiourea, 4% CHAPS 
(w/v) , 0.4% (w/v) carrier ampholytes and 200mM dithiodiethanol (see Note 3). This 
solution is best prepared by sonication in a sonicating bath. It can be kept for months 
frozen at -20°C and thawed before use. 
 
IPG rehydration chamber. This is usually a grooved methacrylate block where the 
widths and lengths of the grooves can accomodate the IPG strips 
 
IPG running device: various chambers exist from different suppliers to run IPG strips. 
Some combine the temperature control device, the power supply in a single 
device,where the rehydration step and the running steps can be carried out 
sequentially without handling the strips in between.  Older devices where the 
rehydration chamber, running chamber, cooling device and power supply are 
separated can however be used with equal success, but they usually require some 
strip handling between rehydration and running 
 
 
2.3. Equilibration and SDS PAGE 
 
20% SDS solution: prepared by adding 200g of pure SDS to 800ml very hot water 
(>90°C) under fast magnetic stirring. Is stable for months at room temperature, but 
SDS may crystallize out if the temperature drops. Should this happen, rewarm at 
37°C and shake until redissolved 
 
60%(v/v) glycerol solution. Stable for months at room temperature 
 
Stacking buffer: 120g/l of Tris and 0.8M HCl 
 
Standard gel buffer: 130g/l of Tris and 0.6M HCl (see Note 4) 
 
Alternate gel buffer 1 ( for low molecular weight proteins): 150g/l of Tris and 0.6M 
HCl 
 
Alternate gel buffer 2 ( for high molecular weight proteins): 110g/l of Tris and 0.6M 
HCl 
 
Acrylamide solution: 30% w/v acrylamide and 0.8% w/v methylene bis acrylamide. 
Best to purchase ready made and is stable at +4°C for months.  
 
Ammonium persulfate solution: 10% w/v ammonium persulfate in water. Made fresh 
every week and kept at room temperature 
 
Temed (tetramethylethylediamine): use as pure liquid. Keep at room temperature 
and stable for months. 
 
Water-saturated butanol. Mix equal volumes of water and 2-butanol. Shake well and 
let the phases separate. Keep at room temperature 
 
Multi gel casting chamber. This accessory usually comes as a bundle with multigel 
running cells (see below) 
 
Multiplate gel running cell. Especially for biomarker discovery, it is recommended to 
run large series of gels in parallel. Several types of such multi-gel cells are 
commercially available. They must be coupled to very powerful cooling device and 
powerful power supplies (not necessary to develop more than 300-500V, but 10-
15W/gel are necessary) (see Note 5).  
 
Tank buffer: Tris 6g/l , taurine 25g/l, SDS 1g/l 
 
Equilibration buffer: for 100ml, mix 12.5 ml stacking buffer, 12.5 ml 20% SDS, 50 ml 
60% glycerol and 36g urea. Make the day of use or at the earliest the day before. 
Needs ca. 30 minutes to dissolve at room temperature but must not be warmed for 
faster dissolution 
 
Sealing agarose: for 100ml, weigh 1g of low-melting agarose and add 12.5 ml 
stacking buffer, 2ml 20% SDS, and water up to 100 ml. Dissolve by heating to >90°C 
(e.g. by short pulses in a microwave oven), then add bromophenol blue (0.04% w/v 
final concentration). Aliquot in 10 ml portions and keep at +4°C.  
 
2.4. Protein detection and image processing 
 
Either commercially available or home made solutions can be used. 
 
Recommended commercial stains are Flamingo from Bio-Rad and Krypton from 
Thermo-Fisher [30] (see Note 6) 
 
For preparing the home-made fluorescent probe concentrate [31], prepare a solution 
containing 20mM ruthenium chloride, 60mM bathophenanthroline disulfonate, 
disodium salt, and 400mM ammonium formate (preferably from a concentrated, 
titrated solution). Either reflux for 3 days or cook for 3 days in an oven set at 95°C 
next to a beaker containing water to saturate the oven with water vapor and thus limit 
the losses in volume by evaporation. The solution should turn very deep orange red. 
Reconstitute at the initial volume with water, and keep in a bottle at +4°C. Stable for 
months at this temperature.  
 
For image acquisition, a laser scanner is ideal. Flamingo is best excited at 515nm 
(emission at 535 nm),  Krypton at  520nm (emission at 580) and the ruthenium 
complex at 488 nm (emission at 600 nm). If laser scanners are not available, a 
chamber containing a 302 nm UV table, coupled with either a CCD camera or a 
simple digital camera and suitable filters (UV + yellow or orange to cut the purple 
emission of the UV tubes) can also be used. In any case, a spatial resolution of at 
least 10 pixels/mm is required 
 
For image analysis, a dedicated software is indispensable. Second-generation 
softwares using image warping as the initial step, are highly recommended.  
 
Fixing solution 1 (Flamingo and Krypton stains): 10% (v/v) acetic acid and 30% (v/v) 
ethanol. Prepare just before use 
 
Fixing solution 2 (ruthenium complex stain) 1% (v/v) of 85% phosphoric acid and 
30% (v/v) ethanol. Prepare just before use. 
 
Staining solution (ruthenium complex stain): 1 µM ruthenium complex in 1% (v/v) of 
85% phosphoric acid and 30% (v/v) ethanol. Prepare just before use. 
 
 
3. Methods 
 
3.1 Sample preparation 
The sample preparation described here is convenient for fluid samples (not tissue or 
cellular samples) that are relatively poor in their protein concentration (down to the 
microgram/ml range) and rather rich in interfering substances such as salts. It is 
derived from work carried out on secreted proteins [32]. However, it must be noted 
that the samples must contain no detergent (Note 7) 
 
If the sample contains more than 0.1M salt, dilute it with water to bring the salt 
concentration below this threshold. Cool the sample on ice, add lauroyl sarcosinate 
to 0.1% (w/v) final concentration. Mix well, then add TCA to 7.5% (w/v) final 
concentration. A voluminous white precipitate forms immediately.  
 
Let the proteins precipitate for 2 hours on ice, then centrifuge at 10,000g at 4°C for 
10 minutes. During this time, cool some tetrahydrofuran on ice. Carefully remove the 
supernatant, then add 1-2ml of cold tetrahydrofuran on the voluminous white pellet. 
The pellet should literally dissolve in the solvent (or leave very fine particles if the 
starting amount of proteins is high).  
 
Centrifuge once again at 10,000g at 4°C for 10 minutes. Remove the supernatant. 
As the pellet is in many occasions completely invisible, it is highly advisable to mark 
the outside of the tubes in the centrifuge, i.e. where the pellet is. This avoids to 
aspirate part of the pellet when removing the supernatant. 
Repeat the cold tetrahydrofuran wash once. Remove the solvent, then let the tubes 
dry open at room temperature for 10-15 minutes. (Note 8) 
 
Then add a minimal volume of protein solubilization solution (100-300µl) and let the 
protein dissolve by sonication for 30 minutes in a sonication bath (Note 9). Recover 
the solution, and measure the protein content by a Bradford-type assay. Then add 
carrier ampholytes to 0.4% (w/v) final concentration and store the sample at -20°C.  
 
3.2. Isoelectric focusing  
 
Take the amount of sample required to have 200µg of proteins (as read by a 
Bradford assay against BSA as a standard). Dilute the sample with IPG rehydration 
solution to reach the adequate strip rehydration volume (Note 10). If the volume of 
added IPG rehydration solution represents less than 50% of the final volume, add 
pure dithiodiethanol to reach a final concentration higher than 100 mM. Add some 
tracking dye (Note 11) so that the solution is lightly colored.  
Add each sample to a groove of the rehydration chamber, then add the IPG strip 
(Note 12). If necessary, cover with mineral oil to prevent evaporation of the water 
and urea crystallization. Let rehydrate overnight (Note 13) at room temperature. 
Then if necessary, transfer the strips in the running chamber. Check the contacts 
with the electrodes. Run the IPG strips under constant voltage with low voltage initial 
steps (Note 14). A recommended running program is the following:  100V for 1 hour, 
then increase from 100V to 300V over 15 minutes, then 300V for 3 hours, then 
increase from 300 to 1000V over 1 hour, then 1 hour at 1000V, increase to 3500V 
over 1 hour and 3500 V constant for at least 15 hours (longer times are not 
detrimental). The movement of the tracking dye becomes usually visible during the 
300V plateau, and is more and more visible at the higher voltage phases. No 
movement of the dye indicates an absence of contact between the IPG gel and the 
electrodes. The tracking dye should collect at the acidic (anodal) part of the gradient. 
If a dyed zone extending beyond the ends of the gradients remains, this is indicative 
of a high conductivity zone (poor salt removal), and it announces poor resolution 2D 
gels at the end.  
 
3.3. SDS gel casting 
 
Ideally, the SDS gels must be cast the day before their use to ensure complete and 
reproducible polymerization. Gel sizes between 150x200 mm and 200x250 mm are 
recommended. Below the 150x200 size, the 2D gels lack resolution, as the total 
resolution is proportional to the gel surface in 2D electrophoresis. Above the 
200x250 size, the gels become too fragile and too many gels are broken during the 
final stages of the experiment. The minimal thickness to accomodate an IPG strip is 
1mm, but 1.5 mm-thick gels are recommended.  
 
Mount the gels assemblies in the multi gel casting chamber. In order to be able to 
differentiate each and every gel of the setup, it is recommended to add a distinctive 
mark cut from thin filter paper  at the bottom of each gel assembly, between the 
glass plates, so that this mark will be embedded in the polyacrylamide gel during 
polymerization. (Note 15). Separate each gel assembly from its neighbors by 
inserting a thin polycarbonate plastic foil (usually supplied with the casting chamber) 
between the gel assemblies. When the gels assemblies are mounted, close the 
casting chamber.  
 
Many casting chambers allow infusion of the gel solution from the bottom, and this is 
the recommended procedure to use. This will however require a funnel and silicone 
tubing to allow casting by gravity. In this case, attach a short piece of silicone tubing 
(ca 10 cm) to the inlet of the casting chamber, and provide with a stopper. Attach a 
long piece of silicone tubing (ca 50 cm) to the outlet of the funnel and provide with a 
stopper. Stoppers that allow easy control of the flow by progressive squeezing of the 
silicone tube are highly recommended. Then unite the two pieces of tubing with a 
plastic linker.  
 
The amount of gel mix needed will of course depend on the size of the gels and on 
the number of gels cast. From the theoretical data (gel dimensions x number of 
gels), calculate the theoretical volume and add 20% more to take into account the 
volume that will be lost between and around the gels in the casting chamber. This 
gives the practical volume needed.  
 
When using the solutions described in section 2, 10%acrylamide gels are easily 
prepared by mixing 1/6 of the practical volume of concentrated gel buffer, 1/3 of the 
practical volume of 30% acrylamide solution and 1/2 of the practical volume of 
distilled water (Note 16). Using the standard gel buffer will lead to a mass window 
spanning the 15-200 kDa window, with optimal resolution in the 15-40 kDa range 
and some crowding above. If a higher resolution of the medium and high molecular 
weight range is desired, use alternate buffer 2. This will lead however to the loss of 
proteins below 20 kDa. Conversely, if low molecular weight proteins (down to 5kDa) 
are of interest, use alternate buffer 1. The use of alternate buffer 1 will however 
increase the crowding in the >30 kDa region of the gel.  
 
When both the gel assemblies and the gel mix are ready, cast the gels. Under slow 
magnetic stirring (no big whirls) add 0.5 µl of TEMED and 5 µl of 10% ammonium 
persulfate solution (in this order) per ml of gel mix. Mix for 20 seconds and pour in 
the casting chamber, avoiding trapping any air bubbles.  Leave a 5mm space at the 
top of the gels, then overlay each gel with 1ml of water-saturated butanol (upper 
phase in the bottle). Then close completely the two stoppers, disconnect the linker 
between the two pieces of tubing, and collect the excess gel mix present in the 
funnel into a beaker. Clean the funnel and the tubing by running distilled water 
through them and let dry. 
Let the gel polymerize, and check for polymerization in the extra gel mix present in 
the beaker. When the gels are polymerized, open the casting chamber and recover 
each gel assembly (plates+ gel). Clean from adhering gel particles under running tap 
water, rinse with distilled water and pile in a closed box, separating once again the 
gel assemblies each one from the other by a clean thin polycarbonate foil. These 
separating foils are cleaned with water and ethanol exactly as the glass plates (see 
Note 15) and can be reused for months.  
Put the closed box containing the gels in the cold room until use. The gels should be 
used 1-3 days after polymerization.  
 
3.4. IPG strip equilibration, transfer to SDS gel, SDS gel running 
 
At the end of the IPG run, the power is switched off, the paper strips at the ends of 
the gels (when present) are removed,  and the mineral or silicon oil covering the 
strips is poured out. It is replaced by at least 10x the strips volume of equilibration 
buffer. Equilibration is carried out for 20 minutes at room temperature, ideally under 
reciprocal ("ping-pong") shaking at ca. 45 strokes per minutes. During the 
equilibration period, the cooling of the second dimension gels is started and the 
agarose is melted, e.g. in a microwave oven. The agarose should be rather hot when 
used, to prevent premature setting of the agarose gel.  
 
The second dimension gels are also put out of the cold room, the groove at their tops 
is carefully dried with a lint free tissue,  and the gels are mounted on their supports to 
receive the strips. 
For each gel, pick a strip with tweezers. X-shaped tweezers, which open only when 
the fingers exert a pressure on them, are ideal for this purpose. Still holding the strip 
by one of its ends, insert the other end of the strip in the groove on top of the second 
dimension gel, pipet 1ml of hot agarose in the groove and complete the transfer of 
the strip. All air bubbles should be carefully removed before the gel sets. If a side 
loading of, e.g, a molecular weight standard is desired, a teflon "tooth" is inserted on 
the side of the second dimension gel at this stage.  
Using the paper shapes present at the bottom of each gel, note which strip (and 
therefore which sample) is loaded on top of which second dimension gel.  
When the agarose gel has set, the Teflon tooth can be removed, leaving an empty 
space to load the control on the side. For example, a 1:1 mixture of sealing agarose 
and molecular weight standard can be loaded, and this let to set again. 
The gels are then mounted in the multi cell, and the tank buffer is poured in the cell.  
Gels are run at 25V constant voltage for 1 hour, then under constant power up to the 
end of the run, until the tracking dye reaches the bottom of the gels (Note 17) 
 
3.5. Protein detection 
 
At the end of the run, turn off the electric power and the cooling device. Remove the 
gels cassettes from the multi gel cell. Wearing gloves, open one gel cassette. Turn 
the glass plate supporting the gel upside down above the box containing the fixing 
solution. Fixing solution 1 is used for Flamingo and Krypton stains, and fixing 
solution 2 for the ruthenium complex stain. Fix the gels for at least 1 hour, then 
continue with the staining process. Follow the manufacturer's instructions for 
Flamingo and Krypton stains.  
For staining with the ruthenium complex, stain overnight with the staining solution, 
then destain for 4-6 hours with fixing solution 2.  Rinse with water for 5-10 minutes 
before image acquisition.  
Scan with the laser scanner or acquire an image on a UV table with the suitable 
camera, then process the images with the image analysis software.  
 
Figure 1 shows an example of the results that can be obtained on a secretome 
sample using the methods described in this chapter.  
 
 
4. Notes 
Note 1: tricholoroacetic acid is highly hygroscopic in its solid state. Thus, is is highly 
advisable to process a complete and new bottle every time to prepare the 100% TCA 
solution.  
 
Note 2: This solution provides a basic pH and a high denaturing power, ideal for 
resolubilizing proteins after precipitation. In addition, it is fully compatible with 
Bradford-type protein assays.  
 
Note 3: dithiodiethanol provides an almost ideal blocking of thiol groups, without 
needing any alkylation step [33]. It increases resolution of the basic proteins in the 
IEF dimensions and simplifies the equilibration process. If desired, thiol alkylation 
can be performed after protein detection and spot excision. 
 
Note 4: Most of the 2D gels run in the world use the classical glycine-based system 
[34]. However, we believe that the taurine-based system[35] offers distinct 
advantages. First, as the gel buffer operates quite close to the pK of Tris, precise 
control of the pH is easier and offers thus better reproducibility over the long term. 
Second, it is much easier to tune the resolution jut by changing the pH of the gel 
buffer, either in the high molecular weight range or in the low molecular weight range  
[35]. Third, as the ionic strength of the buffer (0.1M) is higher than the one of the 
Laemmli system, the resolution is slightly higher and the binding of SDS is also 
higher.  
 
Note 5: Temperature control during SDS PAGE is of great importance to maximize 
resolution and reproducibility. First of all, the higher the migration speed the higher 
the resolution, but only if the gels do not heat. Thus, it is very important to evacuate 
the heat generated during migration by the Joule effect. Due to the geometry of most 
multi gel cells, this requires both a high cooling power and a powerful pump to 
overcome the pressure and flow drops in the multi gel cells. As the final result, the 
optimal migration parameters should be determined empirically and depend both on 
the geometry of the electrophoresis cell and on the power of the cooling apparatus. 
Second, it should be kept in mind that the Tris buffers are among those that show 
the most important changes of pH with the temperature (0.3 pH units/10 °C). Thus, 
temperature stability from run to run is essential to ensure maximal reproducibility of 
the migration.  
 
Note 6: In addition to good compatibility with mass spectrometry, important 
constraints are imposed on the gel detection process. Ideally, the protein detection 
process should be sensitive, linear over several orders of magnitude to be able to 
detect changes both for low- and high-abundance proteins, and homogeneous from 
one protein to another to avoid biases. Recent work has shown that these 
specifications are best met by fluorescent detection using Flamingo and Krypton 
stains [30], which operate by environment sensitive fluorescent probes (the probe is 
not fluorescent in water but fluoresces when bound to proteins).  
 
Note 7: the rationale of the protocol relies on the binding of the lauroyl sarcosinate to 
the proteins and to the co-precipitation of the proteins and of the lauroyl sarcosinate 
as its free acid under very acidic conditions. Other detergents (except bile salts) will 
be soluble under acidic conditions and keep both the lauroyl sarcosinate and the 
proteins soluble even under acidic conditions. The same solubilizing effect is 
obtained for samples containing high concentrations of chaotropes (urea, thiourea, 
guanidine salts). However in this case, efficient precipitation can be obtained if the 
sample is diluted with water to bring the chaotrope concentration below 1M.  
 
Note 8: in this protein precipitation process, the lauroyl sarcosinate acts as a carrier 
and has a dual role. Its first role is to carry down the protein precipitate, as proteins 
do not precipitate well with TCA when they are too dilute (below 1mg/ml) and without 
carrier. The second role of NLS is to decrease the protein-protein interactions within 
the pellet, which greatly helps protein resolubilization of the final stage.  
Tetrahydrofuran has been selected as a washing solvent on a multifactorial rationale. 
First, it is an excellent solvent of both TCA and NLS in its free acid form. Second, it is 
a very poor solvent for proteins, so that they do not redissolve prematurely at this 
stage. Third, tetrahydrofuran is slightly miscible with water, so that traces of the initial 
supernatant will not form a separate phase during the washing process. This 
ensures complete removal of the initial acidic aqueous supernatant. Fourth, 
tetrahydrofuran will be able to remove lipids and other hydrophobic substances that 
may have coprecipitated with the NLS. 
 
Note 9: A sample preparation protocol based on precipitation and resolubilization 
requires that both steps are efficient. Thus, as the proteins are very severely 
precipitated and denatured by TCA, they must be redissolved in highly solubilizing 
solutions, such as concentrated SDS (for SDS PAGE or shotgun based protocols), 
or concentrated chaotropic solutions for 2D PAGE-based protocols. Solubilization in 
intermediate urea concentrations (e.g. 6M urea as in [36]) is inefficient and leads to 
severe protein losses that are not encountered when the sample is properly 
resolubilized [32]. 
 
Note 10: the optimal final rehydration volume depends on the characteristics of the 
strips used. It has been experimentally determined [37] that optimal rehydration 
occurs for final acrylamide concentrations in the rehydrated strip slightly higher than 
3%. Most commercial strips are cast as 4% gels with a 0.5 mm thickness. Then the 
optimal rehydration volume in microliters is given by the formula: strip length (gel part 
only)  in millimeters x strip width in millimeters x 0.65.  
 
Note 11: a tracking dye can be very useful to check for any migration problem. Any 
anionic dye with no affinity to proteins is suitable. Examples include bromophenol 
blue, bromocresol green, Orange G, chicago sky blue. The use of several different 
dyes within a single experiment decreases the probability to change inadvertently the 
strip order. However, it should be kept in mind that many of these tracking dyes have 
pH indicator properties. Thus, bromophenol blue, bromocresol green, Orange G take 
all a similar yellow-orange hue at acidic pH.  
 
Note 12: the ideal pH range for the IPG strip cannot be determined theoretically. It is 
thus advisable to start with a wide pH gradient (e.g. 3-10 linear) and to adapt the pH 
range according to the protein density per pH unit. It should also be kept in mind that 
running purely basic gradients (e.g. 7-10) is more difficult than running gradients 
covering also an acidic part. Thus, it can be interesting to run each sample twice, on 
a 3-10 pH gradient to have a good resolution of the basic proteins, and on a 4-7 
gradient to have adequate resolution of the acidic proteins, which are in most cases 
much more numerous than the neutral or basic ones.  
 
Note 13: It has been described that application of a small voltage (50V) during the 
rehydration step improved protein entry into the pH gradient. This is however 
possible only when the rehydration and running step take place in the same chamber 
and thus depends on the apparatus used 
 
Note 14: Low voltage initial steps are required in order to remove smoothly all low 
molecular weight, charged chemicals (e.g. salts, buffers etc) without generating too 
much Joule heat that would be detrimental to resolution. The program proposed here 
has been empirically determined. It should be kept in mind that isoelectric focusing 
with IPG, on a gradient that is at least 2 pH units wide, requires at least 100Vh/cm2, 
where the numerator is the integration of volts by time and the denominator the 
square of the length of the IPG gel.  
Some manufacturers recommend to apply, after the cleaning step, a defined power 
per strip (generally 50µW/strip), as this ensures the highest possible volt.hours in a 
defined time frame.  However, a purely voltage-limited program is safer. If, in a 
series of samples analyzed in parallel, some are more conductive than others, a 
collective watt-based program will lead to most of the power passing through the 
more conductive samples (P= U2/R). Thus, the more conductive samples will 
dissipate too much power, and consequently too much heat, which will decrease 
resolution. Moreover, when using a collective watt-based program, the running 
profile will be different (in volt.hours) from one series of samples to another. This is 
not the case with a conservative volt-based program as the one described here.  
 
Note 15: the cleanliness of the glass plates is essential to obtain high-quality 2D 
gels. At the end of each run, remove every gel particle from the glass plates by 
brushing them under hot tap water. Then rinse each plate in distilled water and let 
dry. Do not use any detergent to clean the plates, as it is highly likely that some of 
the detergent will stay on the glass plates despite rinsing and will interfere with the 
SDS electrophoresis.  
Just before use, clean again the glass plates with water and then 95% alcohol, using 
a lint-free paper tissue. If the plates are really clean, the alcohol rinsing process 
should produce some wiping noise.  
However, with this cleaning scheme, the plates will become dirty over a time frame 
of several months, and the gel resolution will start to deteriorate. This is easily seen 
when "tails" begin to appear ahead of the most intense spots. When this happens, 
clean thoroughly the glass plates with a mildly abrasive dish cleaning powder and a 
sponge, then rinse profusely under hot tape water, and finally with distilled water.  
 
Note 16: unpolymerized acrylamide is toxic. Wear suitable protection clothes and 
gloves (preferably powder-free nitrile gloves) when handling gels or acrylamide-
containing solutions.  
 
Note 17: the first, initial low voltage step is intended to let the SDS elute completely 
the proteins from the strip. Once the SDS front has passed the strip, the elution 
power is minimal, so that vertical trailing is induced. The gels should be then run at 
maximum speed to limit diffusion, and this maximal speed depends from the gel size, 
the multi gel cell geometry, and the performances of the cooling system. It must 
therefore be determined empirically for each system, but manufacturers of multi gel 
cells generally make useful suggestions in their instructions for use.  
 
 
 
Figure 1:  
J774 murine macrophage cells were seeded in a T175 flask (at 100.000 cells/ml) 
and grown up to confluence in Ultradoma medium supplemented with 1% bovine 
fetal serum (3 days).  The growth medium was then removed, and the cell layer was 
gently rinsed 3 times with PBS at 37°C, then 3 times with serum-free Ultradoma 
medium at 37°C. 25ml of serum-free Ultradoma medium were then added and the 
cells were incubated at 37°C for 24 hours. The conditioned culture medium was then 
collected, centrifuged for 5 minutes at 1000g to remove floating cells, then 
centrifuged for 20 minutes at 10,000g to remove smaller debris. 
The supernatant was then processed using the methods described in this chapter 
(TCA-sarkosyl precipitation, analysis by 2D gels, spot detection by fluorescence), to 
yield the image described in the figure.  
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